DHC

+ Watchlist + Portfolio

Diversified Healthcare Trust

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $8.10
52-Week Range: $3.46 – $9.66
Market Cap: $1.95B
P/E (TTM): —
EPS (TTM): -1.11
Dividend Yield: 0.49%

Advanced Metrics

Price/Book: 1.23
PEG Ratio: 1.89
Return on Equity: -15.47%
Return on Assets: -0.45%
Gross Margin: 18.61%
Operating Margin: -0.14%
Profit Margin: -17.73%
Current Ratio: 6.65
Debt/Equity: 1.53
Total Debt: $2.42B
Free Cash Flow: $258.83M
Revenue Growth: -4.50%
Earnings Growth: —
Enterprise Value: $4.26B

DHC Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$1.28B	$1.41B	$1.50B	$1.54B
Cost of Revenue	$1.11B	$1.17B	$1.24B	$1.26B
Gross Profit	$174.50M	$236.16M	$258.88M	$278.51M
Selling, General & Admin	$26.43M	$26.13M	$26.52M	$45.50M
Operating Expenses	$265.71M	$310.21M	$311.48M	$307.43M
Operating Income	-$91.22M	-$74.06M	-$52.59M	-$28.91M
EBITDA	$427.79M	$203.19M	$148.92M	$145.63M
Pretax Income	-$21.12M	-$272.67M	-$371.38M	-$320.90M
Income Tax	$710.00K	$445.00K	$467.00K	$1.74M
Net Income	-$15.77M	-$293.57M	-$370.25M	-$285.89M
Diluted EPS	-0.07	-1.23	-1.55	-1.19
Diluted Shares	238.31M	238.84M	239.53M	240.29M

DHC Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$658.07M	$245.94M	$144.58M	$105.41M
Receivables	$8.72M	$6.08M	$4.06M	$3.97M
Current Assets	$697.40M	$262.49M	$430.18M	$148.86M
Total Assets	$6.00B	$5.45B	$5.14B	$4.36B
Current Liabilities	$734.62M	$29.94M	$38.10M	$56.81M
Long-Term Debt	$2.35B	$2.82B	$2.91B	$2.40B
Total Debt	$3.05B	$2.82B	$2.91B	$2.40B
Total Liabilities	$3.36B	$3.11B	$3.18B	$2.70B
Retained Earnings	-$1.98B	-$2.28B	-$2.66B	-$2.96B
Shareholders' Equity	$2.64B	$2.34B	$1.96B	$1.67B
Working Capital	-$37.22M	$232.55M	$392.08M	$92.05M
Net Debt	$2.39B	$2.57B	$2.77B	$2.30B

DHC Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$40.35M	$10.48M	$112.22M	-$19.62M
Free Cash Flow	-$40.35M	$10.48M	$112.22M	-$19.62M
Depreciation & Amortisation	$239.53M	$283.84M	$285.06M	$262.04M
Investing Cash Flow	$387.71M	-$202.11M	-$187.02M	$483.57M
Financing Cash Flow	-$676.00M	-$249.71M	-$22.31M	-$492.01M
Dividends Paid	-$9.57M	-$9.60M	-$9.63M	-$9.66M
Share Repurchases	-$171.00K	-$393.00K	-$904.00K	-$1.15M
Net Change in Cash	-$328.64M	-$441.34M	-$97.11M	-$28.05M

DHC Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$386.86M	$382.71M	$388.71M	$379.57M	$366.47M
Cost of Revenue	$314.33M	$312.58M	$325.39M	$307.05M	$290.56M
Gross Profit	$72.54M	$70.13M	$63.32M	$72.52M	$75.92M
Selling, General & Admin	$9.00M	$11.18M	$12.79M	$12.54M	$14.04M
Operating Expenses	$77.33M	$77.44M	$78.11M	$74.54M	$76.95M
Operating Income	-$4.79M	-$7.31M	-$14.79M	-$2.02M	-$1.04M
EBITDA	$115.76M	$23.34M	-$53.77M	$61.08M	$57.24M
Pretax Income	-$10.42M	-$93.88M	-$168.79M	-$47.81M	-$42.75M
Income Tax	$49.00K	$843.00K	$337.00K	$514.00K	$622.00K
Net Income	-$8.99M	-$91.64M	-$164.04M	-$21.22M	-$43.27M
Diluted EPS	-0.04	-0.38	-0.68	—	-0.18
Diluted Shares	239.96M	240.13M	240.38M	—	240.69M

DHC Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$302.58M	$141.77M	$201.37M	$105.41M	$121.77M
Receivables	—	—	—	$3.97M	—
Current Assets	$386.39M	$245.50M	$468.01M	$148.86M	$139.85M
Total Assets	$5.00B	$4.76B	$4.68B	$4.36B	$4.27B
Current Liabilities	$26.93M	$28.98M	$30.01M	$56.81M	$26.08M
Long-Term Debt	$2.80B	$2.64B	$2.72B	$2.40B	$2.40B
Total Debt	$2.80B	$2.64B	$2.72B	$2.40B	$2.40B
Total Liabilities	$3.05B	$2.90B	$3.00B	$2.70B	$2.65B
Retained Earnings	-$2.68B	-$2.77B	-$2.94B	-$2.96B	-$3.01B
Shareholders' Equity	$1.95B	$1.85B	$1.69B	$1.67B	$1.62B
Working Capital	$359.46M	$216.52M	$438.00M	$92.05M	$113.77M
Net Debt	$2.50B	$2.49B	$2.52B	$2.30B	$2.28B

DHC Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	-$3.24M	$53.02M	-$49.28M	-$20.11M	$8.34M
Free Cash Flow	-$3.24M	$53.02M	-$49.28M	-$20.11M	$8.34M
Depreciation & Amortisation	$68.35M	$66.29M	$65.35M	$62.04M	$62.94M
Investing Cash Flow	$291.09M	-$21.05M	$6.12M	$207.42M	$13.58M
Financing Cash Flow	-$131.05M	-$190.04M	$104.21M	-$275.13M	-$3.87M
Dividends Paid	-$2.41M	-$2.41M	-$2.41M	-$2.42M	-$2.42M
Share Repurchases	-$6.00K	-$103.00K	-$954.00K	-$82.00K	-$88.00K
Net Change in Cash	$156.80M	-$158.07M	$61.04M	-$87.82M	$18.05M

Market Snapshot

About

Diversified Healthcare Trust is a real estate investment trust (REIT) that owns medical office buildings, life science properties, and senior living communities across the United States. The company generates revenue through long-term triple-net leases with healthcare operators and providers. Diversified Healthcare focuses on properties serving the aging population, including medical facilities located near major hospital campuses and senior housing communities. The REIT structure allows the company to distribute most taxable income to shareholders as dividends while maintaining a diversified portfolio of healthcare real estate assets.